Personalised or risk-stratified screening offers opportunities to improve the efficiency of cancer screening programmes and reduce their adverse consequences. Polygenic risk score alone or combined with non-genetic risk factors could be used for risk-stratification for risk-tailored screening. Developing and implementing such risk-stratified programmes would require coordination of multi-disciplinary efforts.